Verition Fund Management’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$339K Sell
9,154
-15,037
-62% -$481K ﹤0.01% 1727
2025
Q4
$488K Sell
24,191
-16,706
-41% -$404K ﹤0.01% 2673
2025
Q3
$1.23M Buy
40,897
+29,237
+251% +$633K 0.01% 2364
2025
Q2
$151K Buy
+11,660
New +$111K ﹤0.01% 3428
2024
Q3
Sell
-29,045
Closed -$324K 3149
2024
Q2
$324K Buy
+29,045
New +$338K ﹤0.01% 2296
2023
Q4
Sell
-5,560
Closed -$254K 2296
2023
Q3
$254K Sell
5,560
-500
-8% -$23.2K ﹤0.01% 1838
2023
Q2
$250K Sell
6,060
-17,112
-74% -$561K ﹤0.01% 1696
2023
Q1
$719K Buy
+23,172
New +$746K 0.01% 1077

Other funds holding AEHR

Verition Fund Management's AEHR Position: Q1 2026 in Review

Verition Fund Management reduced its Aehr Test Systems (AEHR) stake by 62% in Q1 2026, selling an estimated $481K and leaving 9,154 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1727.

Verition Fund Management first reported a position in AEHR in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.23M in Q3 2025. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • Verition Fund Management held 9,154 shares of Aehr Test Systems worth $339K as of Q1 2026.
  • Verition Fund Management sold 15,037 Aehr Test Systems shares in Q1 2026, an estimated $481K.
  • Aehr Test Systems made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1727 holding.
  • Verition Fund Management first reported a position in Aehr Test Systems in Q1 2023 and has held it in 8 quarters since.
  • Verition Fund Management's Aehr Test Systems position peaked at $1.23M in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.